
Protai
AI-driven platform for protein-level disease mapping and drug discovery.
About
Protai has developed an end-to-end AI-based platform designed to comprehensively map the progression of diseases at the protein level. This enhances the observation of cellular functions and aims to revolutionize the drug discovery process.
Listed competitors
Show 6 more similar companies
Also in this space
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Biotech
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Drug Development
Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.
Shares Life Sciences, Biotech
Computational platform using LLMs trained on biological and chemical data for drug discovery.
Shares Life Sciences, Generative AI
AI-powered blood test for early cancer detection and subtyping.
Shares Life Sciences, Biotech
Compressing biology to develop the next generation of therapies.
Shares Life Sciences, Drug Discovery
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Protai?
People comparing tools land here. Get listed beside these.
Copy Protai's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- protai.bio
- Headquarters
- Tel Aviv, Israel
- Founded
- 2021
- Founders
- Eran Segal, Kirill Pevzner, Eran Seger
- Employees
- 28
- Total funding
- $20M (Seed)
- Business model
- B2B
Funding rounds
- $12M15 Mar 2023SeedLargest round
- $8M5 Jan 2022
Tech stack
Detected on protai.bio, last scanned 9 Nov 2026. Run your own scan
- CMS / Builders
- Lovable
- CDN
- Cloudflare
- Email provider
- Google Workspace
Benchmarking
See how your site ranks against 16,849 startups
Protai sits in the 30th percentile for Domain Rating. Check where yours lands, free.
Protai has a Domain Rating of 23, the 30th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Below median
Check yoursAgent Readiness
Above median
Scan yoursSite Speed
Top 25%
PageSpeedData Trust
Above median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Protai scores 41. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Protai changes
Used Protai? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Who owns Protai?
Protai is privately held, owned by its founders and investors. Pitango Venture Capital has backed 2 of the 2 rounds on record since January 2022, ahead of Grove Ventures (2), so it is likely among the largest outside shareholders. Exact stakes are not public.
Are there companies like Protai?
Yes. We list 9 companies like Protai, including Insitro, Exscientia and Recursion Pharmaceuticals.
Is Protai trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Protai is 65 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Protai raised?
Protai has raised a total of $20M in funding. The most recent round on record is Seed.
How many employees does Protai have?
Protai has approximately 28 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Protai:
Company details: from public sources. Funding: 2 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Protai and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini


